Important note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.
New York Times (11.11.09) - Thursday, November 12, 2009
Katie Zezima
The proposed legislation would end a 20-year-ban on using federal funding for needle-exchange programs but prohibit federally funded NEPs within 1,000 feet of where children are likely to congregate - a provision that would apply to most of the country's approximately 200 programs.
The bill "is going to kill us," said Ellis Poole, executive director of the Harm Reduction Center of Southern Oregon. The office from which he runs an NEP and an antidrug program for teenagers is less than 1,000 feet away from a high school.
NEPs represent "a critical piece of harm reduction," said Patricia A. Murphy, executive director of the Eastern Maine AIDS Network in Bangor. Her agency runs one of Maine's four NEPs, all of which would be shuttered under the 1,000-foot provision.
The legislation and a separate bill that would disallow city funding as well as federal money for Washington, D.C., NEPs in the 1,000-foot radius have been approved by the House and are awaiting consideration by the full Senate.
"Let's protect these kids," said bill sponsor Jack Kingston, (R-Ga). "They don't need to be playing kickball and seeing people lined up for needle exchange."
Advocates, including the NAACP, are asking Congress to eliminate the 1,000-foot provision.
"The 1,000-foot rule is simply instituting the ban in a different form," said Rebecca Haag, executive director of the AIDS Action Council.
About one-fifth of the nation's 1.1 million HIV cases can be traced directly or indirectly to intravenous drug use, according to CDC. There is "compelling evidence" that NEPs check the spread of HIV, the World Health Organization said in a 2004 report.
091112
AD091941
Copyright © 2009 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.